| Jack Bowie |
Apelon, Inc. |
VP,
Sales & Marketing |
jbowie@
apelon.com
|
(203)
431-2530 Opt. 1, ext. 150 |
LEXICAL AND FIRST DATABANK ANNOUNCE LICENSING AGREEMENT
FDB Drug Data To Be Integrated with Clinical Vocabulary Software
Alameda, CA - February 23, 1998 – Lexical
Technology, Inc., and First DataBank, Inc. today announced that drug
information from First DataBank's National Drug Data File (NDDF)
will be integrated into Lexical Technology's Metaphrase® Thesaurus.
The Metaphrase Thesaurus is the foundation of Lexical's Metaphrase
Enterprise Vocabulary System (EVS).
The Metaphrase EVS is a family of software components and services
for the creation, management, and support of authoritative vocabularies
for healthcare enterprises. Today's healthcare organizations must
manage from facts, and Lexical's Metaphrase components enable these
enterprises to employ standard clinical terminology, create comparable
patient records, and produce meaningful outcomes analysis, decision
support, and reimbursement processes. The Metaphrase Thesaurus is
based on the National Library of Medicine's UMLS® Metathesaurus®,
an integration of more than 40 authoritative coding and terminology
systems used in healthcare.
First DataBank will make available within the Metaphrase Thesaurus
the set of unique code identifiers and descriptive terms that represent
therapeutic classifications, ingredients, generic drug formulations,
and packaged drug products within the NDDF. First DataBank will also
provide the hierarchical relationships required to group packaged
drug products (NDCs) within generic drug formulations. First DataBank
will provide both its own hierarchical organ/pharmacological/therapeutic
classification scheme as well the American Hospital Formulary Service
(AHFS) classifications.
"The addition of comprehensive drug data from First Databank
is a major enhancement to the Metaphrase Thesaurus," said David
Sherertz, founder, President, and CEO of Lexical Technology. "First
DataBank is a leader in the field of clinical drug information and
this partnership will assure that our customers have complete and
accurate information on drugs and drug classifications."
"First DataBank is very pleased that Lexical selected our NDDF
data for integration into Metaphrase," said Jim Wilson, Vice
President of Marketing and Sales for First DataBank. "Lexical's
extensive background and experience in healthcare vocabularies makes
them an ideal partner as we work to better integrate drug and therapeutic
information into decision support, clinical guidelines, and quality
management."
First DataBank Inc., a wholly owned subsidiary of The Hearst Corporation,
develops point-of-care solutions, including knowledge bases and software,
for the pharmacy, medical and nutritional marketplaces. These products
are integral to virtually all segments of the healthcare industry,
including hospitals, pharmacies, insurance companies, physicians,
dieticians and other healthcare professionals. Internet address:
www.firstdatabank.com.
Lexical Technology, Inc., is a privately-held software company headquartered
in Alameda, California. Since its founding in 1984, Lexical has been
recognized as a leading-edge research and technology corporation
that specializes in the development of lexically-based products and
services for healthcare vendors and enterprises. Lexical's Metaphrase
product family, The Common Thread in Medical Terminologies, is the
result of Lexical's ten-years of experience with vocabulary software
systems, including key partnerships with the National Library of
Medicine, the National Cancer Institute, Kaiser Permanente, the Mayo
Clinic, and the American College of Physicians.
Lexical, Metaphrase, Metaphrase Enabled and the Metaphrase Enabled
arrow logo are registered trademarks of Lexical Technology, Inc.
UMLS and Metathesaurus are registered trademarks of the National
Library of Medicine.
Copyright © Apelon,
Inc.
Apelon,
Inc., 100 Danbury Road, Ridgefield, CT
06877
Voice:
203-431-2530 Fax: 203-431-2523
For comments on this
site, contact webmaster@apelon.com.
